Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008 (2008), Article ID 749073, 8 pages
http://dx.doi.org/10.1155/2008/749073
Review Article

Screening for PPAR Responsive Regulatory Modules in Cancer

Life Sciences Research Unit, University of Luxembourg, 1511 Luxembourg, Luxembourg

Received 25 March 2008; Accepted 5 May 2008

Academic Editor: Dipak Panigrahy

Copyright © 2008 Merja Heinäniemi and Carsten Carlberg. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Rhodes, S. Kalyana-Sundaram, V. Mahavisno et al., “Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles,” Neoplasia, vol. 9, no. 2, pp. 166–180, 2007. View at Publisher · View at Google Scholar
  2. D. R. Rhodes and A. M. Chinnaiyan, “Integrative analysis of the cancer transcriptome,” Nature Genetics, vol. 37, no. 6, pp. S31–S37, 2005. View at Publisher · View at Google Scholar
  3. A. Saramäki, C. M. Banwell, M. J. Campbell, and C. Carlberg, “Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor,” Nucleic Acids Research, vol. 34, no. 2, pp. 543–554, 2006. View at Publisher · View at Google Scholar
  4. E. A. Feingold, P. J. Good, M. S. Guyer et al., “The ENCODE (ENCyclopedia of DNA Elements) Project,” Science, vol. 306, no. 5696, pp. 636–640, 2004. View at Publisher · View at Google Scholar
  5. T. S. Mikkelsen, M. Ku, D. B. Jaffe et al., “Genome-wide maps of chromatin state in pluripotent and lineage-committed cells,” Nature, vol. 448, no. 7153, pp. 553–560, 2007. View at Publisher · View at Google Scholar
  6. L. O. Barrera, Z. Li, A. D. Smith et al., “Genome-wide mapping and analysis of active promoters in mouse embryonic stem cells and adult organs,” Genome Research, vol. 18, no. 1, pp. 46–59, 2008. View at Publisher · View at Google Scholar
  7. A. Barski, S. Cuddapah, K. Cui et al., “High-resolution profiling of histone methylations in the human genome,” Cell, vol. 129, no. 4, pp. 823–837, 2007. View at Publisher · View at Google Scholar
  8. O. Hallikas, K. Palin, N. Sinjushina et al., “Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity,” Cell, vol. 124, no. 1, pp. 47–59, 2006. View at Publisher · View at Google Scholar
  9. D. S. Johnson, A. Mortazavi, R. M. Myers, and B. Wold, “Genome-wide mapping of in vivo protein-DNA interactions,” Science, vol. 316, no. 5830, pp. 1497–1502, 2007. View at Publisher · View at Google Scholar
  10. W. J. Kent, C. W. Sugnet, T. S. Furey et al., “The human genome browser at UCSC,” Genome Research, vol. 12, no. 6, pp. 996–1006, 2002. View at Publisher · View at Google Scholar
  11. W. W. Wasserman and A. Sandelin, “Applied bioinformatics for the identification of regulatory elements,” Nature Reviews Genetics, vol. 5, no. 4, pp. 276–287, 2004. View at Publisher · View at Google Scholar
  12. S. Sperling, “Transcriptional regulation at a glance,” BMC Bioinformatics, vol. 8, supplement 6, article S2, pp. 1–6, 2007. View at Publisher · View at Google Scholar
  13. S. J. M. Jones, “Prediction of genomic functional elements,” Annual Review of Genomics and Human Genetics, vol. 7, pp. 315–338, 2006. View at Publisher · View at Google Scholar
  14. V. Laudet, J. Auwerx, J.-A. Gustafsson, and W. Wahli, “A unified nomenclature system for the nuclear receptor superfamily,” Cell, vol. 97, no. 2, pp. 161–163, 1999. View at Publisher · View at Google Scholar
  15. I. Issemann and S. Green, “Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators,” Nature, vol. 347, no. 6294, pp. 645–650, 1990. View at Publisher · View at Google Scholar
  16. A. Chawta, J. J. Repa, R. M. Evans, and D. J. Mangelsdorf, “Nuclear receptors and lipid physiology: opening the X-files,” Science, vol. 294, no. 5548, pp. 1866–1870, 2001. View at Publisher · View at Google Scholar
  17. G. Krey, O. Braissant, F. L'Horset et al., “Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay,” Molecular Endocrinology, vol. 11, no. 6, pp. 779–791, 1997. View at Publisher · View at Google Scholar
  18. T. M. Willson, P. J. Brown, D. D. Sternbach, and B. R. Henke, “The PPARs: from orphan receptors to drug discovery,” Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 527–550, 2000. View at Publisher · View at Google Scholar
  19. L. Michalik, B. Desvergne, and W. Wahli, “Peroxisome-proliferator-activated receptors and cancers: complex stories,” Nature Reviews Cancer, vol. 4, no. 1, pp. 61–70, 2004. View at Publisher · View at Google Scholar
  20. L. Michalik, B. Desvergne, C. Dreyer, M. Gavillet, R. N. Laurini, and W. Wahli, “PPAR expression and function during vertebrate development,” International Journal of Developmental Biology, vol. 46, no. 1, pp. 105–114, 2002. View at Google Scholar
  21. A. L. Bookout, Y. Jeong, M. Downes, R. T. Yu, R. M. Evans, and D. J. Mangelsdorf, “Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network,” Cell, vol. 126, no. 4, pp. 789–799, 2006. View at Publisher · View at Google Scholar
  22. J. P. Vanden Heuvel, “The PPAR resource page,” Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 1108–1112, 2007. View at Publisher · View at Google Scholar
  23. L. Michalik, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptors β/δ: emerging roles for a previously neglected third family member,” Current Opinion in Lipidology, vol. 14, no. 2, pp. 129–135, 2003. View at Publisher · View at Google Scholar
  24. S. Heikkinen, J. Auwerx, and C. A. Argmann, “PPARγ in human and mouse physiology,” Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 999–1013, 2007. View at Publisher · View at Google Scholar
  25. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer, “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ),” Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953–12956, 1995. View at Google Scholar
  26. S. Kersten, B. Desvergne, and W. Wahli, “Roles of PPARS in health and disease,” Nature, vol. 405, no. 6785, pp. 421–424, 2000. View at Publisher · View at Google Scholar
  27. S. A. Kliewer, K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans, “Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors,” Nature, vol. 358, no. 6389, pp. 771–774, 1992. View at Publisher · View at Google Scholar
  28. A. IJpenberg, E. Jeannin, W. Wahli, and B. Desvergne, “Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element,” Journal of Biological Chemistry, vol. 272, no. 32, pp. 20108–20117, 1997. View at Publisher · View at Google Scholar
  29. M. Heinäniemi, J. O. Uski, T. Degenhardt, and C. Carlberg, “Meta-analysis of primary target genes of peroxisome proliferator-activated receptors,” Genome Biology, vol. 8, no. 7, article R147, pp. 1–29, 2007. View at Publisher · View at Google Scholar
  30. A. Aranda and A. Pascual, “Nuclear hormone receptors and gene expression,” Physiological Reviews, vol. 81, no. 3, pp. 1269–1304, 2001. View at Google Scholar
  31. L. J. Burke and A. Baniahmad, “Co-repressors 2000,” The FASEB Journal, vol. 14, no. 13, pp. 1876–1888, 2000. View at Publisher · View at Google Scholar
  32. F. L. Khanim, L. M. Gommersall, V. H. J. Wood et al., “Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells,” Oncogene, vol. 23, no. 40, pp. 6712–6725, 2004. View at Publisher · View at Google Scholar
  33. F. Molnár, M. Matilainen, and C. Carlberg, “Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators,” Journal of Biological Chemistry, vol. 280, no. 28, pp. 26543–26556, 2005. View at Publisher · View at Google Scholar
  34. V. Perissi and M. G. Rosenfeld, “Controlling nuclear receptors: the circular logic of cofactor cycles,” Nature Reviews Molecular Cell Biology, vol. 6, no. 7, pp. 542–554, 2005. View at Publisher · View at Google Scholar
  35. T. Jenuwein and C. D. Allis, “Translating the histone code,” Science, vol. 293, no. 5532, pp. 1074–1080, 2001. View at Publisher · View at Google Scholar
  36. M. L. Acevedo and W. L. Kraus, “Transcriptional activation by nuclear receptors,” Essays in Biochemistry, vol. 40, pp. 73–88, 2004. View at Google Scholar
  37. R. Métivier, G. Penot, M. R. Hübner et al., “Estrogen receptor-a directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter,” Cell, vol. 115, no. 6, pp. 751–763, 2003. View at Publisher · View at Google Scholar
  38. S. Kangaspeska, B. Stride, R. Métivier et al., “Transient cyclical methylation of promoter DNA,” Nature, vol. 452, no. 7183, pp. 112–115, 2008. View at Publisher · View at Google Scholar
  39. A. Galaup, A. Cazes, S. Le Jan et al., “Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 49, pp. 18721–18726, 2006. View at Publisher · View at Google Scholar
  40. E. A. Nikitin, S. G. Malakho, B. V. Biderman et al., “Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia,” Leukemia and Lymphoma, vol. 48, no. 5, pp. 912–922, 2007. View at Publisher · View at Google Scholar
  41. S. Chen, G. Bu, Y. Takei et al., “Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells,” Journal of Cell Science, vol. 120, no. 22, pp. 4009–4015, 2007. View at Publisher · View at Google Scholar
  42. S. A. Tahir, G. Yang, A. A. Goltsov et al., “Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer,” Cancer Research, vol. 68, no. 3, pp. 731–739, 2008. View at Publisher · View at Google Scholar
  43. M. Baniyash, “Chronic inflammation, immunosuppression and cancer: new insights and outlook,” Seminars in Cancer Biology, vol. 16, no. 1, pp. 80–88, 2006. View at Publisher · View at Google Scholar
  44. D. S. Straus and C. K. Glass, “Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms,” Trends in Immunology, vol. 28, no. 12, pp. 551–558, 2007. View at Publisher · View at Google Scholar
  45. T.-C. He, T. A. Chan, B. Vogelstein, and K. W. Kinzler, “PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs,” Cell, vol. 99, no. 3, pp. 335–345, 1999. View at Publisher · View at Google Scholar
  46. B. H. Park, B. Vogelstein, and K. W. Kinzler, “Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2598–2603, 2001. View at Publisher · View at Google Scholar
  47. S. Müller-Brüsselbach, M. Kömhoff, and M. Rieck, “Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ-deficient mice,” The EMBO Journal, vol. 26, no. 15, pp. 3686–3698, 2007. View at Publisher · View at Google Scholar
  48. S. Mader, P. Leroy, J.-Y. Chen, and P. Chambon, “Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors,” Journal of Biological Chemistry, vol. 268, no. 1, pp. 591–600, 1993. View at Google Scholar
  49. M. Schräder, K. M. Müller, M. Becker-André, and C. Carlberg, “Response element selectivity for heterodimerization of vitamin D receptors with retinoic acid and retinoid X receptors,” Journal of Molecular Endocrinology, vol. 12, no. 3, pp. 327–339, 1994. View at Google Scholar
  50. M. Schräder, K. M. Müller, and C. Carlberg, “Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone,” Journal of Biological Chemistry, vol. 269, no. 8, pp. 5501–5504, 1994. View at Google Scholar
  51. M. Schräder, M. Becker-André, and C. Carlberg, “Thyroid hormone receptor functions as monomeric ligand-induced transcription factor on octameric half-sites. Consequences also for dimerization,” Journal of Biological Chemistry, vol. 269, no. 9, pp. 6444–6449, 1994. View at Google Scholar
  52. X. Xie, J. Lu, E. J. Kulbokas et al., “Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals,” Nature, vol. 434, no. 7031, pp. 338–345, 2005. View at Publisher · View at Google Scholar
  53. V. Matys, E. Fricke, R. Geffers et al., “TRANSFAC®: transcriptional regulation, from patterns to profiles,” Nucleic Acids Research, vol. 31, no. 1, pp. 374–378, 2003. View at Publisher · View at Google Scholar
  54. D. G. Lemay and D. H. Hwang, “Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics,” Journal of Lipid Research, vol. 47, no. 7, pp. 1583–1587, 2006. View at Publisher · View at Google Scholar
  55. D. T. Odom, R. D. Dowell, E. S. Jacobsen et al., “Tissue-specific transcriptional regulation has diverged significantly between human and mouse,” Nature Genetics, vol. 39, no. 6, pp. 730–732, 2007. View at Publisher · View at Google Scholar
  56. J. L. Burns, D. A. Jackson, and A. B. Hassan, “A view through the clouds of imprinting,” The FASEB Journal, vol. 15, no. 10, pp. 1694–1703, 2001. View at Publisher · View at Google Scholar
  57. E. Portales-Casamar, S. Kirov, J. Lim et al., “PAZAR: a framework for collection and dissemination of cis-regulatory sequence annotation,” Genome Biology, vol. 8, no. 10, article R207, pp. 1–12, 2007. View at Publisher · View at Google Scholar
  58. E. Sbisà, D. Catalano, G. Grillo et al., “p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data,” BMC Bioinformatics, vol. 8, supplement 1, article S20, pp. 1–12, 2007. View at Publisher · View at Google Scholar
  59. T. Degenhardt, M. Matilainen, K.-H. Herzig, T. W. Dunlop, and C. Carlberg, “The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors,” Journal of Biological Chemistry, vol. 281, no. 51, pp. 39607–39619, 2006. View at Publisher · View at Google Scholar
  60. H. Liu, C. Zang, M. H. Fenner et al., “Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARa/? ligand TZD18,” Blood, vol. 107, no. 9, pp. 3683–3692, 2006. View at Publisher · View at Google Scholar
  61. R. J. Perera, E. G. Marcusson, S. Koo et al., “Identification of novel PPAR? target genes in primary human adipocytes,” Gene, vol. 369, no. 1-2, pp. 90–99, 2006. View at Publisher · View at Google Scholar
  62. K. Tachibana, Y. Kobayashi, T. Tanaka et al., “Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing PPAR isoforms,” Nuclear Receptor, vol. 3, article 3, pp. 1–17, 2005. View at Publisher · View at Google Scholar
  63. J.-I. Hisatake, T. Ikezoe, M. Carey, S. Holden, S. Tomoyasu, and H. P. Koeffler, “Down-regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor γ in human prostate cancer,” Cancer Research, vol. 60, no. 19, pp. 5494–5498, 2000. View at Google Scholar
  64. S. Karahatay, K. Thomas, S. Koybasi et al., “Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C18-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis,” Cancer Letters, vol. 256, no. 1, pp. 101–111, 2007. View at Publisher · View at Google Scholar